-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to a public account report, yesterday, Xi’an Janssen President An Sijia announced to employees that he would integrate and establish a new neuroscience, anti-infection and vaccine product business unit, and promote Wang Yu to vice president and head of this business unit.
It is reported that this business unit will focus on diversified product lines and innovative business models, integrating from the original psychiatric business unit, neurology business unit, anti-infective business unit, and the upcoming vaccine business unit.
It is understood that Wang Yu once held positions such as product manager and deputy business director at GlaxoSmithKline and Pfizer Pharmaceuticals.